BackSilence Therapeutics Plc Overview
Silence Therapeutics Plc - ADR

Silence Therapeutics Plc Target Price

See Silence Therapeutics Plc's analyst price targets ($20) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$19.83

Average Target Price

$20.000.9% upside

2 analysts in the last 4 months

High: $20 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-10-21H.C. WainwrightPatrick Trucchio$200.9% upsideOpen
2026-10-19Jefferies$200.9% upsideOpen
2024-06-28Chardan CapitalKeay Nakae$55177.4% upsideOpen
2024-06-28Morgan StanleyMichael Ulz$49147.1% upsideOpen
2024-03-13BMO CapitalKostas Biliouris$67237.9% upsideOpen
2022-12-09Morgan Stanley$189.2% downsideOpen
2022-11-17Chardan Capital$2946.2% upsideOpen

Silence Therapeutics Plc (SLN) FAQ

The latest target price for SLN is $20. Investors often review this figure alongside Silence Therapeutics Plc's historical trend and sector peers before judging valuation or financial health.

Silence Therapeutics Plc trades near $19.83 while the consensus target sits at $20 (0.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting SLN's target price ($20), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Silence Therapeutics Plc's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.